You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

 

Online download statistics by month:

Online download statistics by month: September 2022 to March 2026

AbstractFullPdf
Sep 2022615635330
Oct 2022892940458
Nov 2022335341165
Dec 2022199201117
Jan 2023231237139
Feb 2023242245130
Mar 2023188190110
Apr 2023160163113
May 2023153154107
Jun 2023172173110
Jul 2023142142113
Aug 202316716791
Sep 202314814996
Oct 2023151152100
Nov 2023164165120
Dec 2023116116100
Jan 2024143144125
Feb 2024146148124
Mar 2024183189210
Apr 2024187187148
May 2024166167130
Jun 202412912982
Jul 2024152154111
Aug 202413012680
Sep 2024117120114
Oct 2024151151134
Nov 2024170172133
Dec 2024212217157
Jan 2025157157115
Feb 2025182182132
Mar 2025141143123
Apr 2025175175133
May 2025165166145
Jun 2025878759
Jul 2025220
Aug 2025110
Mar 2026110
Total687269884654